BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

326 related articles for article (PubMed ID: 26205068)

  • 1. Daxx and TCF4 interaction links to oral squamous cell carcinoma growth by promoting cell cycle progression via induction of cyclin D1 expression.
    Lin GJ; Huang YS; Lin CK; Huang SH; Shih HM; Sytwu HK; Chen YW
    Clin Oral Investig; 2016 Apr; 20(3):533-40. PubMed ID: 26205068
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acylglycerol kinase promotes the proliferation and cell cycle progression of oral squamous cell carcinoma.
    Liu G; Ren X; Gao C; Zhang W
    Mol Med Rep; 2015 Aug; 12(2):2225-30. PubMed ID: 25872568
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Knocking-down of CREPT prohibits the progression of oral squamous cell carcinoma and suppresses cyclin D1 and c-Myc expression.
    Ma J; Ren Y; Zhang L; Kong X; Wang T; Shi Y; Bu R
    PLoS One; 2017; 12(4):e0174309. PubMed ID: 28369091
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The human HECA interacts with cyclins and CDKs to antagonize Wnt-mediated proliferation and chemoresistance of head and neck cancer cells.
    Dowejko A; Bauer R; Bauer K; Müller-Richter UD; Reichert TE
    Exp Cell Res; 2012 Mar; 318(5):489-99. PubMed ID: 22100912
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TEAD4-YAP interaction regulates tumoral growth by controlling cell-cycle arrest at the G1 phase.
    Takeuchi S; Kasamatsu A; Yamatoji M; Nakashima D; Endo-Sakamoto Y; Koide N; Takahara T; Shimizu T; Iyoda M; Ogawara K; Shiiba M; Tanzawa H; Uzawa K
    Biochem Biophys Res Commun; 2017 Apr; 486(2):385-390. PubMed ID: 28315328
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cyclin D1 expression and its possible regulation in chewing tobacco mediated oral squamous cell carcinoma progression.
    Mishra R; Das BR
    Arch Oral Biol; 2009 Oct; 54(10):917-23. PubMed ID: 19679297
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epithelial cell transforming sequence 2 in human oral cancer.
    Iyoda M; Kasamatsu A; Ishigami T; Nakashima D; Endo-Sakamoto Y; Ogawara K; Shiiba M; Tanzawa H; Uzawa K
    PLoS One; 2010 Nov; 5(11):e14082. PubMed ID: 21124766
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pin1 is overexpressed in oral squamous cell carcinoma and its levels correlate with cyclin D1 overexpression.
    Miyashita H; Mori S; Motegi K; Fukumoto M; Uchida T
    Oncol Rep; 2003; 10(2):455-61. PubMed ID: 12579289
    [TBL] [Abstract][Full Text] [Related]  

  • 9. QKI-5 suppresses cyclin D1 expression and proliferation of oral squamous cell carcinoma cells via MAPK signalling pathway.
    Fu X; Feng Y
    Int J Oral Maxillofac Surg; 2015 May; 44(5):562-7. PubMed ID: 25457822
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IFITM3 knockdown reduces the expression of CCND1 and CDK4 and suppresses the growth of oral squamous cell carcinoma cells.
    Gan CP; Sam KK; Yee PS; Zainal NS; Lee BKB; Abdul Rahman ZA; Patel V; Tan AC; Zain RB; Cheong SC
    Cell Oncol (Dordr); 2019 Aug; 42(4):477-490. PubMed ID: 30949979
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Toll-like receptor-9 agonists increase cyclin D1 expression partly through activation of activator protein-1 in human oral squamous cell carcinoma cells.
    Min R; Siyi L; Wenjun Y; Shengwen L; Ow A; Lizheng W; Chenping Z
    Cancer Sci; 2012 Nov; 103(11):1938-45. PubMed ID: 22853846
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overexpression of angiopoietin 2 promotes the formation of oral squamous cell carcinoma by increasing epithelial-mesenchymal transition-induced angiogenesis.
    Li C; Li Q; Cai Y; He Y; Lan X; Wang W; Liu J; Wang S; Zhu G; Fan J; Zhou Y; Sun R
    Cancer Gene Ther; 2016 Sep; 23(9):295-302. PubMed ID: 27492854
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostics of Cyclin-D1 expression with chemoradiation response in patients of locally advanced oral squamous cell carcinoma.
    Khan H; Gupta S; Husain N; Misra S; Singh N; Negi MP
    J Cancer Res Ther; 2014; 10(2):258-64. PubMed ID: 25022375
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cyclin D1 expression in oral squamous cell carcinoma and verrucous carcinoma: correlation with histological differentiation.
    Angadi PV; Krishnapillai R
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2007 Mar; 103(3):e30-5. PubMed ID: 17197212
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of cyclin D1 expression by cyclin D1 shRNAs in human oral squamous cell carcinoma cells is associated with increased cisplatin chemosensitivity.
    Zhou X; Zhang Z; Yang X; Chen W; Zhang P
    Int J Cancer; 2009 Jan; 124(2):483-9. PubMed ID: 18942709
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of p16/MTS1, cyclin D1 and RB in primary oral cancer and oral cancer cell lines.
    Sartor M; Steingrimsdottir H; Elamin F; Gäken J; Warnakulasuriya S; Partridge M; Thakker N; Johnson NW; Tavassoli M
    Br J Cancer; 1999 Apr; 80(1-2):79-86. PubMed ID: 10389982
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The oncogenic role of androgen receptors in promoting the growth of oral squamous cell carcinoma cells.
    Wu TF; Luo FJ; Chang YL; Huang CM; Chiu WJ; Weng CF; Hsu YK; Yuan TC
    Oral Dis; 2015 Apr; 21(3):320-7. PubMed ID: 25040852
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression status of Pin1 and cyclins in oral squamous cell carcinoma: Pin1 correlates with Cyclin D1 mRNA expression and clinical significance of cyclins.
    Miyashita H; Uchida T; Mori S; Echigo S; Motegi K
    Oncol Rep; 2003; 10(4):1045-8. PubMed ID: 12792768
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of cyclin D1 correlates with p27
    Guan G; Bakr MM; Firth N; Love RM
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2018 Aug; 126(2):174-183. PubMed ID: 29550080
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Semaphorin7A Promotion of Tumoral Growth and Metastasis in Human Oral Cancer by Regulation of G1 Cell Cycle and Matrix Metalloproteases: Possible Contribution to Tumoral Angiogenesis.
    Saito T; Kasamatsu A; Ogawara K; Miyamoto I; Saito K; Iyoda M; Suzuki T; Endo-Sakamoto Y; Shiiba M; Tanzawa H; Uzawa K
    PLoS One; 2015; 10(9):e0137923. PubMed ID: 26378920
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.